Skip to content

Randomized Trial of a Quality Improvement Intervention to Decrease D2B Time in Primary PCI for AMI

Randomized Trial of Aggressive Process of Care Quality Improvement Intervention to Decrease Door to Balloon Time in Primary PCI for Acute Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01625104
Acronym
RAPID-PCI
Enrollment
882
Registered
2012-06-21
Start date
2003-09-30
Completion date
2006-12-31
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Keywords

Myocardial Infarction, Time to Treatment, Door to Balloon Time

Brief summary

The primary objective of this study is to assess whether an aggressive quality improvement intervention strategy will decrease time from hospital presentation to first balloon inflation in non-transfer patients with acute ST segment elevation MI (STEMI) treated with primary percutaneous coronary intervention (PCI). Twelve hospitals in Michigan were randomized to either aggressive intervention or control. The intervention consisted of Grand Rounds at each hospital, sharing of best practices, and coordinating center staff working closely with staff at each intervention hospital to discuss solutions to barriers to rapid treatment for STEMI patients.

Detailed description

The participating hospitals randomized to the aggressive intervention strategy actively worked to create teams to analyze processes of care for STEMI patients, identify areas needing improvement, and implemented strategies to streamline treatment. Hospitals randomized to control were instructed to conduct business as usual.

Interventions

OTHERNon Intervention

Business as usual

OTHERAgressive Intervention Process Improvement Strategies

Sponsors

Blue Cross Blue Shield of Michigan Foundation
CollaboratorOTHER
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Acute ST segment myocardial infarction, non transfer patients, with symptom onset to balloon time less than or equal to 24 hours.

Exclusion criteria

* Patients transferred from one facility to another, * non ST segment myocardial infarction patients.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Sites With Reduction in Door to Balloon TimeArrival to balloon inflation, measured in minutes (generally less than 120 mins)Arrival time in Emergency Department to first balloon inflation in the coronary artery. Any reduction in median Door to Balloon Time from baseline to follow-up was counted as reduction in time

Countries

United States

Participant flow

Recruitment details

6 sites were randomized to the aggressive strategy and 6 sites were randomized to control.

Pre-assignment details

Site were randomized according to baseline Door to Balloon times.

Participants by arm

ArmCount
Group 1: Agressive Intervention
Hospitals were randomized to an aggressive intervention strategy or to business as usual. The hospitals randomized to the aggressive intervention strategy underwent the following: 1. Grand Rounds conducted by physician and nurse from the Coordinating Center. This included a formal presentation on the evidence supporting rapid time to treatment in STEMI patients and evidence based strategies for reducing treatment delays. 2. Discussion with staff regarding perceived barriers to treatment and suggestions/ideas for strategies to overcome these barriers 3. Follow-up monthly phone conferences to continue to discuss strategies and ideas sharing 4. Written plan from sites detailing plans to change processes of care.
448
Group 2: Control Strategy
Hospitals randomized to the control group were instructed to conduct business as usual. Business as usual was described as site specific protocol for treatment of STEMI patient +/- any ongoing quality improvement efforts. No specific recommendations were given to sites from the coordinating center.
434
Total882

Baseline characteristics

CharacteristicGroup 1: Agressive InterventionGroup 2: Control StrategyTotal
Age, Continuous61.2 years
STANDARD_DEVIATION 13.2
60.2 years
STANDARD_DEVIATION 12.4
60.7 years
STANDARD_DEVIATION 12.8
Sex: Female, Male
Female
136 Participants134 Participants270 Participants
Sex: Female, Male
Male
312 Participants300 Participants612 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 4480 / 434
serious
Total, serious adverse events
0 / 4480 / 434

Outcome results

Primary

Percentage of Sites With Reduction in Door to Balloon Time

Arrival time in Emergency Department to first balloon inflation in the coronary artery. Any reduction in median Door to Balloon Time from baseline to follow-up was counted as reduction in time

Time frame: Arrival to balloon inflation, measured in minutes (generally less than 120 mins)

ArmMeasureValue (NUMBER)
Group 1: Aggressive StategyPercentage of Sites With Reduction in Door to Balloon Time83 percentage of sites with improved D2B
Group 2: Control StrategyPercentage of Sites With Reduction in Door to Balloon Time50 percentage of sites with improved D2B

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026